Kryptomed Formulations Private Limited, a active private limited company, was established on 20 July 2016 in Chandigarh, Chandigarh, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24230CH2016PTC041139. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Kirti Mehta (Director), Anshul Madan (Director), Vipin Kumar (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sco 827, Second Floor Nac Manimajra, Chandigarh, Chandigarh, Chandigarh, 160101.
U24230CH2016PTC041139
041139
20 July 2016
₹1.00 M
₹0.10 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Kryptomed Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kirti Mehta | Director | 20 Jul 2016 | Current |
| Anshul Madan | Director | 20 Jul 2016 | Current |
| Vipin Kumar | Director | 20 Jul 2016 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kryptomed Formulations Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 23.26% increase. The company also saw a substantial improvement in profitability, with a 33.64% increase in profit. The company's net worth Soared by an impressive increase of 43.65%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Kryptomed Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Kryptomed Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kryptomed Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kryptomed Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Kryptomed Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Kryptomed Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was recorded as a recent event.
Progress on Kirti Mehta was appointed as a Director was appointed as a Director on 20 Jul 2016 & has been associated with this company since 9 years 4 months . was documented.
The activity Anshul Madan was appointed as a Director was appointed as a Director on 20 Jul 2016 & has been associated with this company since 9 years 4 months . was completed.
Vipin Kumar was appointed as a Director was appointed as a Director on 20 Jul 2016 & has been associated with this company since 9 years 4 months . was recorded as a recent event.
The activity Kryptomed Formulations Private Limited was registered on 20 Jul 2016 with Roc Chandigarh & aged 9 years 4 months as per MCA records. was completed.
The CIN of Kryptomed Formulations Private Limited is U24230CH2016PTC041139.
Kryptomed Formulations Private Limited is headquartered at Sco 827, Second Floor Nac Manimajra, Chandigarh, Chandigarh, Chandigarh, 160101.
Kryptomed Formulations Private Limited was incorporated on 20 July 2016.
The current directors of Kryptomed Formulations Private Limited are
The primary industry of Kryptomed Formulations Private Limited is Trade.
Kryptomed Formulations Private Limited is unlisted.
The authorized capital of Kryptomed Formulations Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Kryptomed Formulations Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX